Home phototherapy for hyperbilirubinemia in term neonates—an unblinded multicentre randomized controlled trial
Open Access
- 19 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 180 (5), 1603-1610
- https://doi.org/10.1007/s00431-021-03932-4
Abstract
The aim of this study was to assess whether home phototherapy was feasible and safe in a cohort of otherwise healthy term-born neonates who fulfilled the criteria for in-hospital phototherapy. This was a randomized controlled trial in which term newborns with a total serum bilirubin of 18–24 mg/dL (300–400 μmol) were randomized to either home phototherapy or conventional in-hospital phototherapy. The primary outcome measurements were safety and efficacy, length of stay and the number of failed treatments. The secondary outcomes were the number of blood samples and weight gain during treatment. One hundred forty-seven patients were recruited, 69 patients randomized to conventional phototherapy and 78 to home phototherapy. The results showed that no patients needed blood exchange and only 4% of the patients allocated to home phototherapy were admitted to the hospital. The duration of phototherapy, length of stay, amount of blood tests and weight change showed no statically significant differences. Conclusion: Home phototherapy could be a safe alternative to inpatient phototherapy for otherwise healthy newborns with hyperbilirubinemia if daily checkups and 24/7 telephone support can be provided. The parents should be informed to contact the hospital immediately if they fail to perform the treatment at home. Trial registration: Clinicaltrials.gov NCT03536078 What is Known: • Phototherapy in the hospital is a safe and effective treatment without major side effects. • Fibre optic equipment has made the choice of home phototherapy possible. What is New: • This is the first randomized controlled trial comparing home phototherapy with hospital phototherapy. • Results indicate that home phototherapy could be considered as a safe and feasible alternative when performed according to instructions given, to hospital treatment for otherwise healthy term newborns.Keywords
Funding Information
- Region Örebro län
This publication has 19 references indexed in Scilit:
- Home- versus hospital-based phototherapy for the treatment of non-haemolytic jaundice in infants at more than 37 weeks' gestationEmergencias, 2014
- Efficacy of light‐emitting diode versus other light sources for treatment of neonatal hyperbilirubinemia: a systematic review and meta‐analysisActa Paediatrica, 2012
- Neonatal jaundice: summary of NICE guidanceBMJ, 2010
- Acute management of extreme neonatal jaundice---the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulationActa Paediatrica, 2008
- Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of GestationPEDIATRICS, 2004
- Fibreoptic phototherapy for neonatal jaundiceEmergencias, 2001
- Home phototherapy for neonatal jaundice - technology and team work meeting consumer and service needAustralian Health Review, 2000
- Comparison of the efficacy of fiberoptic and conventional phototherapy for neonatal hyperbilirubinemiaThe Journal of Pediatrics, 1994
- Home PhototherapyClinical Pediatrics, 1986
- INFLUENCE OF LIGHT ON THE HYPERBILIRUBINÆMIA OF INFANTSThe Lancet, 1958